Delaware Company - Nasdaq Or Nyse Listing Options

SPACs cost north of 1.5 million in addition to about 30% equity dilution by SPAC sponsors and bankers, but this exceptionally clean Delaware company doesn’t come with this inherited substantial dilution as the SPAC.

We specialize in institutional funding for up to 350 million post-listing, collateralized by the company's NASDAQ stock, along with the NASDAQ and New York Stock Exchange direct listings.

Direct listings have emerged as an attractive alternative to traditional initial public offerings (IPOs) as the financial landscape continues to shift. A straight public listing offers the Company a few appealing advantages.

This method, we believe, has the potential to boost the Company's growth prospects while also providing a variety of benefits to your shareholders and stakeholders.

The traditional IPO process systematically underprices the stock of companies who use it.
From 1980 to 2020, companies going through the traditional IPO process have underpriced their stock by an average of 20% and left a collective $200 billion on the table.

In 2020 alone was even worse with an average of 48% underpricing, and $30 billion left on the table.ct post NASDAQ or NYSE listing.